| General Information of Drug Metabolite (DM) (ID: DM005037) |
| DM Name |
Capmatinib M16
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Aldehyde oxidase (AOX1)
|
DME0052
|
| Unclear - Unclear |
Capmatinib
|
[1] |
|
Xanthine dehydrogenase/oxidase (XDH)
|
DME0070
|
| Unclear - Unclear |
Capmatinib
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Capmatinib |
DR5347
|
Approved |
Lung cancer |
|
|
| References |
| 1 |
Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
